Concept Life Sciences, a scientific laboratory and consultancy group, has acquired Agenda1 Analytical Services
Concept Life Sciences acquires Agenda1
Agenda 1 is an analytical company delivering support to pharmaceutical, healthcare and medical device companies.
Concept Life Sciences CEO Alan Morgan said: ”Agenda1 has a very strong business model merging significant capability and skilled staff with a positive reputation.
“By combining innovative and unrestricted thinking they have successfully created a problem-solving flexibility that is invaluable to its customers. This approach is complementary to Concept Life Sciences’ established business base.”
Agenda 1 managing director Ian Siragher will continue to lead the business. Siragher said: “The timing of this acquisition is very positive as we have been expanding our range of services to better meet clients’ demands.
“The investment from Concept Life Sciences means we can not only continue to do this but expedite the process whilst benefiting from being part of a larger team.”